A promising new biologic prognostic model in diffuse large B-cell lymphoma

被引：1
|
作者：
Nathwani, Bharat N. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
BLOOD | 2012年 / 120卷 / 11期
关键词：
SURVIVAL; RITUXIMAB; SUBTYPES; PREDICTS;
D O I：
10.1182/blood-2012-07-441253
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2161 / 2162
页数：4
相关论文
共 50 条
  • [1] A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma
    Perry, Anamarija M.
    Cardesa-Salzmann, Teresa M.
    Meyer, Paul N.
    Colomo, Luis
    Smith, Lynette M.
    Fu, Kai
    Greiner, Timothy C.
    Delabie, Jan
    Gascoyne, Randy D.
    Rimsza, Lisa
    Jaffe, Elaine S.
    Ott, German
    Rosenwald, Andreas
    Braziel, Rita M.
    Tubbs, Raymond
    Cook, James R.
    Staudt, Louis M.
    Connors, Joseph M.
    Sehn, Laurie H.
    Vose, Julie M.
    Lopez-Guillermo, Armando
    Campo, Elias
    Chan, Wing C.
    Weisenburger, Dennis D.
    BLOOD, 2012, 120 (11) : 2290 - 2296
  • [2] Diffuse large B-cell lymphoma - a new look and old prognostic factors
    Dobrea, Camelia
    Al Salamat, Hamed
    Lupu, Anca Roxana
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2012, 20 (04): : 307 - 315
  • [3] An integrated prognostic model for diffuse large B-cell lymphoma treated with immunochemotherapy
    Rodriguez, Marta
    Alonso-Alonso, Ruth
    Fernandez-Miranda, Ismael
    Mondejar, Rufino
    Cereceda, Laura
    Trascasa, Alvaro
    Conceicao, Anabel Antonio-Da
    Borregon, Jennifer
    Gato, Lucia
    Tomas-Roca, Laura
    Barcena, Carmen
    Iglesias, Begona
    Climent, Fina
    Gonzalez-Barca, Eva
    Camacho, Francisca Inmaculada
    Mayordomo, Empar
    Olmedilla, Gabriel
    Gomez-Prieto, Pilar
    Castro, Yolanda
    Serrano-Lopez, Juana
    Sanchez-Garcia, Joaquin
    Montes-Moreno, Santiago
    Garcia-Cosio, Monica
    Martin-Acosta, Paloma
    Garcia, Juan F.
    Planelles, Maria
    Quero, Cristina
    Provencio, Mariano
    Mahillo-Fernandez, Ignacio
    Rodriguez-Pinilla, Socorro M.
    Derenzini, Enrico
    Pileri, Stefano
    Sanchez-Beato, Margarita
    Cordoba, Raul
    Piris, Miguel A.
    EJHAEM, 2022, 3 (03): : 722 - 733
  • [4] Significance of stromal-1 and stromal-2 signatures and biologic prognostic model in diffuse large B-cell lymphoma
    Abdou, Asmaa Gaber
    Asaad, Nancy
    Kandil, Mona
    Shabaan, Mohammed
    Shams, Asmaa
    CANCER BIOLOGY & MEDICINE, 2017, 14 (02) : 151 - 161
  • [5] Prognostic implication of leucocyte subpopulations in diffuse large B-cell lymphoma
    Han, Xiao
    Ruan, Jing
    Zhang, Wei
    Zhou, Daobin
    Xu, Dongsheng
    Pei, Qiang
    Ouyang, Mingqi
    Zuo, Mengxuan
    ONCOTARGET, 2017, 8 (29) : 47790 - 47800
  • [6] Identification and Validation of a Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma
    Yan, Jiaqin
    Yuan, Wei
    Zhang, Junhui
    Li, Ling
    Zhang, Lei
    Zhang, Xudong
    Zhang, Mingzhi
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [7] Refining the prognostic impact of the cell of origin in diffuse large B-cell lymphoma
    Balague, O.
    Campo, E.
    ANNALS OF ONCOLOGY, 2017, 28 (05) : 918 - 920
  • [8] Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic Impact
    Devin, Julie
    Kassambara, Alboukadel
    Bruyer, Angelique
    Moreaux, Jerome
    Bret, Caroline
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (07)
  • [9] Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma
    Kim, Eugene
    Jiang, Yanwen
    Xu, Tao
    Bazeos, Alexandra
    Knapp, Andrea
    Bolen, Christopher R.
    Humphrey, Kathryn
    Nielsen, Tina G.
    Penuel, Elicia
    Paulson, Joseph N.
    BMC CANCER, 2022, 22 (01)
  • [10] Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes
    Sun, Yao
    Joks, Monika
    Xu, Li-Ming
    Chen, Xiu-Li
    Qian, Dong
    You, Jin-Qiang
    Yuan, Zhi-Yong
    ONCOTARGETS AND THERAPY, 2016, 9 : 2069 - 2080
12345